3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
22
Cisplatin
17
Surveys and Questionnaires
8
Radiotherapy
8
Carboplatin
8
Radiotherapy, Intensity-Modulated
7
Cetuximab
7
Paclitaxel
6
Nivolumab
6
Drug Therapy
6
Radiation
4
Fluorouracil
4
Taxes
3
Docetaxel
3
selpercatinib
2
dostarlimab
2
Yoga
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
Chemoradiotherapy
2
Blood Specimen Collection
2
ALX148
2
veliparib
1
tisotumab vedotin
1
tislelizumab
1
palbociclib
1
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Head and Neck Neoplasms
×
Biopsy, Large-Core Needle
×
Clear all
NCT05520099
2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
416 enrolled